Med-tech financing slows in Q2 as follow-ons lead a mixed first half

Source Summary

Total med-tech financing through the first half (H1) of 2026 reached $12.66 billion, down from 2025’s $17.56 billion but in line with 2024’s $13.94 billion over the same period. The 2026 H1 total remains well below the stronger years of 2019 through 2021, when H1 figures consistently cleared $20 billion or more, suggesting that while med-tech financing has recovered it has yet to regain its pre-pandemic momentum. The first quarter (Q1) was considerably stronger than the second, with $8.81 billion in Q1 followed by $3.84 billion in Q2, the weakest quarter since 2023.